Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transcription factor c-Myb: novel prognostic factor in osteosarcoma.
Říhová K, Dúcka M, Zambo IS, Vymětalová L, Šrámek M, Trčka F, Verner J, Drápela S, Fedr R, Suchánková T, Pavlatovská B, Ondroušková E, Kubelková I, Zapletalová D, Tuček Š, Múdry P, Krákorová DA, Knopfová L, Šmarda J, Souček K, Borsig L, Beneš P. Říhová K, et al. Among authors: suchankova t. Clin Exp Metastasis. 2022 Apr;39(2):375-390. doi: 10.1007/s10585-021-10145-4. Epub 2022 Jan 7. Clin Exp Metastasis. 2022. PMID: 34994868
Toll-Like Receptor 3 Overexpression Induces Invasion of Prostate Cancer Cells, whereas Its Activation Triggers Apoptosis.
Muresan XM, Slabáková E, Procházková J, Drápela S, Fedr R, Pícková M, Vacek O, Víchová R, Suchánková T, Bouchal J, Kürfürstová D, Král M, Hulínová T, Sýkora RP, Študent V, Hejret V, van Weerden WM, Puhr M, Pustka V, Potěšil D, Zdráhal Z, Culig Z, Souček K. Muresan XM, et al. Among authors: suchankova t. Am J Pathol. 2022 Sep;192(9):1321-1335. doi: 10.1016/j.ajpath.2022.05.009. Epub 2022 Jun 22. Am J Pathol. 2022. PMID: 35750257 Free article.
The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel-resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe.
Drápela S, Khirsariya P, van Weerden WM, Fedr R, Suchánková T, Búzová D, Červený J, Hampl A, Puhr M, Watson WR, Culig Z, Krejčí L, Paruch K, Souček K. Drápela S, et al. Among authors: suchankova t. Mol Oncol. 2020 Oct;14(10):2487-2503. doi: 10.1002/1878-0261.12756. Epub 2020 Jul 16. Mol Oncol. 2020. PMID: 32579780 Free PMC article.
Synthesis and Profiling of a Novel Potent Selective Inhibitor of CHK1 Kinase Possessing Unusual N-trifluoromethylpyrazole Pharmacophore Resistant to Metabolic N-dealkylation.
Samadder P, Suchánková T, Hylse O, Khirsariya P, Nikulenkov F, Drápela S, Straková N, Vaňhara P, Vašíčková K, Kolářová H, Binó L, Bittová M, Ovesná P, Kollár P, Fedr R, Ešner M, Jaroš J, Hampl A, Krejčí L, Paruch K, Souček K. Samadder P, et al. Among authors: suchankova t. Mol Cancer Ther. 2017 Sep;16(9):1831-1842. doi: 10.1158/1535-7163.MCT-17-0018. Epub 2017 Jun 15. Mol Cancer Ther. 2017. PMID: 28619751
Presence of growth/differentiation factor-15 cytokine in human follicular fluid, granulosa cells, and oocytes.
Souček K, Malenovská A, Kahounová Z, Remšík J, Holubcová Z, Soukup T, Kurfürstová D, Bouchal J, Suchánková T, Slabáková E, Hampl A. Souček K, et al. Among authors: suchankova t. J Assist Reprod Genet. 2018 Aug;35(8):1407-1417. doi: 10.1007/s10815-018-1230-5. Epub 2018 Jun 13. J Assist Reprod Genet. 2018. PMID: 29948426 Free PMC article.
MEK inhibitors block growth of lung tumours with mutations in ataxia-telangiectasia mutated.
Smida M, Fece de la Cruz F, Kerzendorfer C, Uras IZ, Mair B, Mazouzi A, Suchankova T, Konopka T, Katz AM, Paz K, Nagy-Bojarszky K, Muellner MK, Bago-Horvath Z, Haura EB, Loizou JI, Nijman SM. Smida M, et al. Among authors: suchankova t. Nat Commun. 2016 Dec 6;7:13701. doi: 10.1038/ncomms13701. Nat Commun. 2016. PMID: 27922010 Free PMC article.
21 results